Variant report
Variant | esv1794928 |
---|---|
Chromosome Location | chr5:27524711-27539490 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:27530537..27533471-chr5:27821180..27823240,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs549562427 | chr5:27530216-27530217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73073612 | chr5:27530237-27530238 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs532051518 | chr5:27530238-27530239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550232906 | chr5:27530252-27530253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368432597 | chr5:27530255-27530256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs571954973 | chr5:27530292-27530293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs199614100 | chr5:27530334-27530335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189935922 | chr5:27530347-27530348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs2329626 | chr5:27530378-27530379 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs149110584 | chr5:27530399-27530400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs141846392 | chr5:27530418-27530419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201477547 | chr5:27530428-27530429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572034936 | chr5:27530459-27530460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183706667 | chr5:27530531-27530532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115312407 | chr5:27530539-27530540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs576130268 | chr5:27530541-27530542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543581864 | chr5:27530542-27530543 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs558615697 | chr5:27530574-27530575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576720045 | chr5:27530632-27530633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187331780 | chr5:27530668-27530669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576740420 | chr5:27530706-27530707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560070771 | chr5:27530774-27530775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144818528 | chr5:27530791-27530792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs542724517 | chr5:27530802-27530803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561409913 | chr5:27530830-27530831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531841814 | chr5:27530831-27530832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550339458 | chr5:27530845-27530846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565624289 | chr5:27530860-27530861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573989018 | chr5:27530880-27530881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372666972 | chr5:27530881-27530882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532806815 | chr5:27530900-27530901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547424872 | chr5:27530904-27530905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75188772 | chr5:27530931-27530932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs377442518 | chr5:27530934-27530935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536369871 | chr5:27530936-27530937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545636922 | chr5:27530998-27530999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557914454 | chr5:27531009-27531010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138655892 | chr5:27531025-27531026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192057492 | chr5:27531035-27531036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536891904 | chr5:27531049-27531050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs376643359 | chr5:27531131-27531132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142882672 | chr5:27531170-27531171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559502114 | chr5:27531188-27531189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576730618 | chr5:27531191-27531192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs78518994 | chr5:27531208-27531209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534569121 | chr5:27531228-27531229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553769556 | chr5:27531292-27531293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs578211595 | chr5:27531297-27531298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372826906 | chr5:27531299-27531300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs183675870 | chr5:27531315-27531316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27530200-27531800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr5:27531600-27532400 | Enhancers | H9 Cell Line | embryonic stem cell |
3 | chr5:27531800-27532400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr5:27531800-27532400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr5:27531800-27532400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:27532400-27533400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr5:27532400-27533600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
8 | chr5:27533200-27533600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr5:27533400-27533600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
10 | chr5:27533800-27534000 | Enhancers | HUES48 Cell Line | embryonic stem cell |